Healthcare -
Biotechnology - NASDAQ - US
$ 3.79
-3.56 %
$ 131 M
Market Cap
-4.03
P/E
GNLX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity GNLX - Genelux Corporation
27.9 M
LAST VALUE
85.27%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR